Viewing Study NCT02394093


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-03-03 @ 4:17 AM
Study NCT ID: NCT02394093
Status: COMPLETED
Last Update Posted: 2016-09-19
First Post: 2015-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate the Bioavailability of a Single Oral Dose of the Acetylsalicylic Acid Containing Dry Powder 500 mg in Comparison to the Bioavailability of a Single Oral Dose of Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adults.
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-02
Start Date Type: None
Primary Completion Date: 2015-03
Primary Completion Date Type: ACTUAL
Completion Date: 2015-03
Completion Date Type: ACTUAL
First Submit Date: 2015-03-14
First Submit QC Date: None
Study First Post Date: 2015-03-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-09-16
Last Update Post Date: 2016-09-19
Last Update Post Date Type: ESTIMATED